loading

Finanzdaten der Ekso Bionics Holdings Inc-Aktie (EKSO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
39.05%
2.057
3.375 4.95 3.756
Cost Of Revenue
21.10%
1.238
1.569 2.313 1.805
Gross Profit
54.65%
0.819
1.806 2.637 1.951
Operating Expenses
8.62%
4.794
5.246 4.972 5.207
Benefits Costs and Expenses
-
- - -
Costs And Expenses
11.49%
6.032
6.815 7.285 7.012
Operating Income/Loss
15.55%
-3.975
-3.44 -2.335 -3.256
Nonoperating Income/Loss
130.60%
1.266
0.549 -0.081 -0.173
Income/Loss From Continuing Operations Before Tax
171.15%
2.057
-2.891 4.95 -3.429
Income/Loss From Continuing Operations After Tax
6.30%
-2.709
-2.891 -2.416 -3.429
Net Income/Loss
6.30%
-2.709
-2.891 -2.416 -3.429
Preferred Stock Dividends And Other Adjustments
-
- - -
Attributable To Noncontrolling Interest
-
- - -
Basic Average Shares
91.41%
2.18
25.39 18.22 17.42
Basic Earnings Per Share
933.33%
-1.24
-0.12 -0.13 -0.20
Diluted Earnings Per Share
933.33%
-1.24
-0.12 -0.13 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - -
$169.78
price up icon 1.78%
$85.83
price up icon 1.95%
medical_instruments_supplies COO
$83.74
price down icon 0.12%
$75.02
price up icon 0.07%
medical_instruments_supplies WST
$273.93
price down icon 1.47%
$41.42
price up icon 2.67%
Kapitalisierung:     |  Volumen (24h):